Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
What will the orphan drug landscape look like in 2024?
Big pharma's recent dominance of the orphan market has fuelled calls to reform the orphan drug act in the US. Regardless, orphan drug sales are forecast to increase from $119bn in 2018 to $217bn in 2024.
Download your copy of the EvaluatePharma Orphan Drug Report 2020 to learn more, including: